XOMA Royalty (XOMA) Non Operating Income (2011 - 2020)
XOMA Royalty (XOMA) reported Non Operating Income of -$1.2 million for Q4 2020, down 269.06% on a YoY basis from $698558.2 in Q1 2020, and down 173.26% sequentially from $1.6 million in Q3 2020.
XOMA Royalty (XOMA) Non Operating Income (2011 - 2020) Analysis & Trends
XOMA Royalty (XOMA) has 10 years of Non Operating Income data on file, last reported at -$1.2 million in Q4 2020.
- For the quarter ending Q4 2020, Non Operating Income fell 269.06% year-over-year to -$1.2 million; the trailing twelve-month figure through Dec 2020 stood at -$619000.0 (down 132.53% YoY), and the FY2020 full-year result was -$1.2 million, down 269.06% from the prior year.
- Non Operating Income fell to -$1.2 million in Q4 2020, from $1.6 million in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $5.6 million in Q1 2016 to a low of -$1.2 million in Q4 2020.
- A 5-year average of $597750.0 and a median of $299500.0 in 2018 frame the typical range for Non Operating Income.
- Across the five-year window, Non Operating Income surged 3185.71% in 2017 and tumbled 269.06% in 2020, its largest moves.
- Tracing XOMA's Non Operating Income over 5 years: stood at -$21000.0 in 2016, then jumped by 3185.71% to $648000.0 in 2017, then plunged by 51.85% to $312000.0 in 2018, then sank by 202.56% to -$320000.0 in 2019, then plunged by 269.06% to -$1.2 million in 2020.
- Business Quant data shows XOMA's Non Operating Income at -$1.2 million in Q4 2020, $1.6 million in Q3 2020, and -$382000.0 in Q2 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -9.22 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 188.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 5.75 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -8.59 Mn |
| 10 | XOMA Royalty | 478.42 Mn | 412.34 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | -1.18 Mn |
| Sep 30, 2020 | 1.61 Mn |
| Jun 30, 2020 | -382,000.00 |
| Mar 31, 2020 | -668,000.00 |
| Dec 31, 2019 | -320,000.00 |
| Sep 30, 2019 | 287,000.00 |
| Jun 30, 2019 | 639,000.00 |
| Mar 31, 2019 | 1.30 Mn |
| Dec 31, 2018 | 312,000.00 |
| Sep 30, 2018 | 729,000.00 |
| Jun 30, 2018 | 1.04 Mn |
| Mar 31, 2018 | 1.33 Mn |
| Dec 31, 2017 | 648,000.00 |
| Sep 30, 2017 | -600,000.00 |
| Jun 30, 2017 | -1.03 Mn |
| Mar 31, 2017 | 205,000.00 |
| Dec 31, 2016 | -21,000.00 |
| Sep 30, 2016 | -433,000.00 |
| Jun 30, 2016 | 2.86 Mn |
| Mar 31, 2016 | 5.62 Mn |